Ge Long Hui A P P·2026-01-09 10:11Core Viewpoint - Junshi Biosciences (688180.SH) announced that its controlling shareholder and chairman, Mr. Xiong Jun, plans to increase his holdings in the company's A-shares and H-shares by at least RMB 100 million over a 12-month period starting from April 12, 2025 [1] Group 1 - Mr. Xiong intends to invest no less than RMB 50 million in A-shares as part of this plan [1] - As of the announcement date, Mr. Xiong has already acquired 100,000 A-shares through the Shanghai Stock Exchange, representing approximately 0.01% of the company's total share capital, with a total transaction amount of RMB 3.8384 million [1] - The share acquisition plan is still in progress, and Mr. Xiong will continue to purchase shares at opportune times during the implementation period [1]